GGrantIndex
Sort

146,196 grants matching diabetes

SEARCH For Diabetes in Youth, Phase 3: Cohort Study-Carolina Center

$698,437
Elizabeth J Mayer-Davis · Univ Of North Carolina Chapel Hill · U18 · FY2013 · DP

Rare Sequence Variation and Diabetes Quantitative Traits

$698,431
James B Meigs · Massachusetts General Hospital · U01 · FY2017 · DK

Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification

$698,404
Daniel Joseph Cox · University Of Virginia · R01 · FY2017 · DK

Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities

$698,403
Julie A Schmittdiel · Kaiser Foundation Research Institute · R18 · FY2015 · DK

Role and Regulation of Skeletal Muscle Mitochondrial Dynamics in Type 2 Diabetes

$698,401
John P. Kirwan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · DK

Role and Regulation of Skeletal Muscle Mitochondrial Dynamics in Type 2 Diabetes

$698,401
John P. Kirwan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · DK

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems

$698,400
Mandana Khalili · University Of California, San Francisco · R01 · FY2024 · AA

Pharmacogenomic studies in VISP: results & implications for clinical trial design

$698,373
Michele M Sale · University Of Virginia · U01 · FY2011 · HG

Confounder-Corrected Quantitative MRI Biomarkers of Hepatic

$698,355
Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2014 · DK

Impact of Pregnancy, Obesity, and Vitamin D Binding Protein on Vitamin D Kinetics

$698,306
Kimberly O O'Brien · Cornell University · R01 · FY2024 · HD

HIV Testing in Dental Care Settings

$698,277
Lisa R Metsch · University Of Miami School Of Medicine · R01 · FY2009 · DE

Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models

$698,268
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Epigenetic Risk Factors for AD Age at Onset and Health Disparities: HABLE Epigenetics Study

$698,248
Robert Clinton Barber · University Of North Texas Hlth Sci Ctr · R01 · FY2022 · AG

Improve PAD PERformance with METformin. The PERMET Trial

$698,232
Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2021 · HL

GENE EXPRESSION IN DIABETES BY SUBTRACTIVE CLONING

$698,231
Joslin Diabetes Center · R01 · FY2002 · DK

Epidemiology of Obesity, Diabetes, and Hypertension in African Caribbeans

$698,209
Iva Miljkovic · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · HL

Engineering an Atherosclerosis-Resistant Endothelium

$698,204
Martin A. Schwartz · University Of Virginia · R01 · FY2008 · HL

Preclinical optimization of a gene therapy for erythromelalgia and chronic pain

$698,171
Fernando Aleman Guillen · Navega Therapeutics, Inc. · U44 · FY2021 · NS

The Two Sister Study

$698,168
Clarice Weinberg · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

Molecular Biophysics of Mitochondrial Membranes

$698,134
Yuriy Kirichok · Washington University · R35 · FY2023 · GM

Precision imaging of electromechanical coupling for non-invasive cardiac arrhythmia mapping

$698,129
Elaine Y Wan · Columbia University Health Sciences · R01 · FY2025 · HL

Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens

$698,106
Danwei Huangfu · Sloan-Kettering Inst Can Research · U01 · FY2021 · DK

Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens

$698,106
Danwei Huangfu · Sloan-Kettering Inst Can Research · U01 · FY2024 · DK

Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens

$698,106
Danwei Huangfu · Sloan-Kettering Inst Can Research · U01 · FY2023 · DK

Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens

$698,106
Danwei Huangfu · Sloan-Kettering Inst Can Research · U01 · FY2022 · DK